Previous 10 |
home / stock / cmiiu / cmiiu news
Universe Pharmaceuticals (UPC) +113%.Humanigen (HGEN) +61% on positive Phase 3 data for COVID-19 therapy.Cyanotech Corporation (CYAN) +48%.Big Rock Partners Acquisition (BRPA) +42%.SeaChange International (SEAC) +34% on multi-million-dollar contract with broadband service provider.F...
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify. Archegos implosionWall Street is on tenterhooks as the fallout from a hedge fund implosion that roiled the stock market Friday moves to its second trading ...
Transaction combines SomaLogic’s comprehensive proteomics technology platform with CM Life Sciences II, a leading life science-focused SPAC, led by affiliates of institutional investors Casdin Capital and Corvex Management. Combination is expected to provide up to $651 mill...
SPAC CM Life Sciences (CMIIU), the SPAC backed by activist Keith Meister’s Corvex Management LP and life-sciences investor Casdin Capital, is reportedly nearing a transaction to take protein-analysis company SomaLogic Inc. public.The deal, which could be announced as soon as...
One IPO and 29 SPACs went public this past week to close out February. 29 SPACs raised $10.7 billion, led by Jeff Sagansky and Harry Sloan's Soaring Eagle Acquisition, which raised $1.5 billion in the largest blank check IPO of 2021 to date. The Renaissance IPO Indices are market ...
News, Short Squeeze, Breakout and More Instantly...
CM Life Sciences II Inc. Unit Company Name:
CMIIU Stock Symbol:
NASDAQ Market:
CM Life Sciences II Inc. Unit Website:
SomaLogic to debut on Nasdaq as a leading publicly traded AI-data driven proteomics platform company Business combination results in approximately $630 million in gross cash proceeds to catalyze organic and inorganic growth initiatives Combined company to trade on ...
NEW YORK and BOULDER, Colo., Aug. 23, 2021 (GLOBE NEWSWIRE) -- CM Life Sciences II (NASDAQ: CMIIU) and SomaLogic, Inc. (“SomaLogic” or the “Company”), a leader in AI-data driven proteomics technology, today announced that with the approach of the business combina...
BOULDER, Colo. & SOUTH SAN FRANCISCO, Calif., Aug. 18, 2021 (GLOBE NEWSWIRE) -- CM Life Sciences II (Nasdaq: CMIIU) and SomaLogic, Inc., a leader in AI-data driven proteomics technology, and Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its...